Metformin Active Not Recruiting Phase 4 Trials for Polycystic Ovarian Syndrome (PCOS) / Syndrome, Metabolic / Fatty Liver, Non-alcoholic Fatty Liver Disease, NAFLD Treatment

Indications	Status	Purpose	Phase
DBCOND0062250 (Polycystic Ovarian Syndrome (PCOS)) DBCOND0136716 (Syndrome, Metabolic) DBCOND0050561 (Fatty Liver, Non-alcoholic Fatty Liver Disease, NAFLD)	Active Not Recruiting	Treatment	4

clinicaltrials.gov Identifier	Title	Drugs
NCT02500147	Metformin for Ectopic Fat Deposition and Metabolic Markers in Polycystic Ovary Syndrome (PCOS)	Metformin (DB00331)